Related Experiment Video

Updated: May 22, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

[Challenges in the antimicrobial treatment of infective endocarditis. Role of daptomycin]

Benito Almirante1, José M Miró

  • 1Servicio de Enfermedades Infecciosas, Hospital Universitario Vall d'Hebron, Barcelona, España. balmiran@vhebron.net

Enfermedades Infecciosas Y Microbiologia Clinica
|May 1, 2012
PubMed

Insights

Daptomycin is a promising new antibiotic for treating difficult Gram-positive infections, including those resistant to other drugs. It shows good efficacy, safety, and potential synergy with other treatments.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Rising antibiotic resistance in Gram-positive bacteria poses a significant therapeutic challenge.
  • First-line antibiotics are becoming less effective against multi-resistant strains.
  • Glycopeptides show limited efficacy in severe infections like infective endocarditis.

Purpose:

  • To evaluate the clinical efficacy and safety of daptomycin for Gram-positive bacterial infections.
  • To highlight daptomycin's potential as a first-line treatment option.
  • To discuss daptomycin's role in managing antibiotic-resistant infections.

Summary:

  • Daptomycin demonstrates good clinical efficacy and safety in treating serious Gram-positive infections.
  • It exhibits bactericidal activity and synergistic potential with other antibiotics like beta-lactams.
  • Daptomycin is a viable option for infections caused by resistant staphylococci and enterococci.

Impact:

  • Daptomycin offers an effective alternative for infections unresponsive to conventional therapies.
  • Its favorable safety profile and low resistance rate are significant advantages.
  • Further research is needed to fully establish daptomycin's role in specific severe infections.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...